Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Autologous TGF beta resistant HER2 EBV CTLs |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
Autologous TGF beta resistant HER2 EBV CTLs are EBV-specific autologous cytotoxic T lymphocytes that express a chimeric ERBB2 (HER2) antigen receptor as well as a dominant negative TGF-beta receptor, which target ERBB2 (HER2) expressing tumor cells, potentially resulting in increased CTL-mediated tumor cell death (NCI Drug Dictionary). |
| DrugClasses | HER2 (ERBB2) Immune Cell Therapy 9 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Autologous TGF beta resistant HER2 EBV CTLs | Autologous TGF beta resistant HER2 EBV CTLs | 0 | 1 |